Lancôme launches topical longevity skincare with Timeline

Key takeaways

• Lancôme has launched its first longevity‑targeted skincare vary developed with Swiss biotech Timeline.
• The vary introduces Mitopure® (Urolithin A) into topical magnificence for the primary time.
• The molecule targets the pores and skin’s organic age by way of mitophagy‑pushed mobile renewal.
• The launch indicators Lancôme’s broader push into longevity science and precision magnificence diagnostics.
• The brand new vary will debut on the 2026 American Academy of Dermatology Annual Assembly.

Lancôme’s new longevity‑based mostly skincare vary is the primary client launch produced in partnership with the Swiss longevity biotech agency Timeline since L’Oréal Groupe invested within the firm in 2024.

Bringing longevity biotechnology into mainstream skincare

The vary, which can be unveiled on the American Academy of Dermatology (AAD) Annual Assembly from 27–29 March, introduces Mitopure (Urolithin A) into topical skincare.

The clinically studied longevity molecule, derived from pomegranate ellagitannins, has beforehand been utilized in oral longevity‑targeted dietary supplements. It’s designed to behave on the pores and skin’s organic age quite than ship brief‑time period beauty results.

For Lancôme, the launch indicators a transfer to translate longevity science into client magnificence at scale, bringing a class that has largely remained area of interest inside dietary supplements and wellness clinics into mainstream skincare.

Mitopure: the molecule powering Lancôme’s new vary

Mitopure is a proprietary molecule backed by greater than $50 million in R&D and 15 years of analysis, is a extremely pure type of Urolithin A — a postbiotic clinically confirmed to re‑energise mitochondria, the powerhouses of the cell, by way of a renewal course of generally known as mitophagy.

In keeping with Vania Lacascade, World Model President of Lancôme, longevity is a frontier of radical progress, not a matter of look. “We’re defining a brand new scientific period the place magnificence is proactive, decoding the core organic mechanisms of pores and skin growing older,” she stated. “By orchestrating significant partnerships with the world’s most superior biotech innovators – like Timeline and its Mitopure® molecule – we’re accelerating our mission to pioneer high-performance options. Our objective is to shift the dialog on growing older, utilizing cutting-edge science to revive mobile vitality and supply ladies a brand new perspective on their very own pores and skin’s trajectory.”

In the meantime, Chris Rinsch, co-founder and President of Timeline, stated the collaboration marks an thrilling new chapter for the corporate. “This partnership presents a exceptional alternative to democratise our longevity molecule, Mitopure®, making its superior pores and skin advantages extra extensively accessible than ever,” he stated.

Lancôme’s rising give attention to mobile ageing and pores and skin healthspan

Lancôme believes this chapter represents a serious scientific breakthrough, opening a brand new societal paradigm that’s not about masking the indicators of time however decoding the elemental organic mechanisms to protect and restore pores and skin healthspan.

The model has lately positioned larger emphasis on longevity science. In 2025, it launched Absolue Longevity The Delicate Cream, powered by patent‑pending Absolue PDRN, which is understood to reinforce cell longevity metabolism and reverse seen indicators of ageing layer by layer.

Final yr, Lancôme additionally showcased its Precision Magnificence Tech (Cell BioPrint). By way of a partnership with Korean begin‑up NanoEnTek, the model developed a primary‑of‑its‑variety “lab‑on‑chip” pores and skin evaluation answer. Utilizing proteomics and microfluidics to analyse pores and skin‑floor protein biomarkers, Cell BioPrint determines the organic age of the pores and skin floor and fashions future pores and skin‑magnificence longevity trajectories. thus permitting prospects to shift from ‘reactive correction’ to extra proactive, information‑pushed care.